Results 91 to 100 of about 640,932 (312)

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego, Kellee Parker, William C. Thomsen, James B. Ford, Mallorie B. Heneghan, David Spencer Mangum, Jennifer L. McNeer, Luke D. Maese, Claire E. F. Miller, Richard Lemons, Taumoha Ghosh   +10 more
wiley   +1 more source

The Impacts of Firms' Research and Development Capacities on Innovation Development

Verimlilik Dergisi
Purpose: The main objective of this study is to measure the effects of R&D capacities of firms operating in Türkiye, registered in Borsa Istanbul and having R&D centers on innovation development.Methodology: In this research, the panel data analysis ...
Saim Aydın, Erdinç Koç
doaj   +1 more source

Tax Incentives for Scientific and Technological Development: Experience of Foreign Countries and Russia [PDF]

Финансовый журнал
The priority directions of the state policy of the Russian Federation on the development of investment activities in the country in projects related to the achievement of technological sovereignty and structural adaptation of the economy makes necessary ...
Ludmila V. Polezharova, Denis M. Volkov
doaj   +1 more source

R&D Productivty: an International Study [PDF]

The objective of this paper is to explore the impact of R&D expenditures on company performance. R&D activities play an essential role in the future economic development and financial performance of firms.
Hervé, STOLOWY, Michel, TENENHAUS, Yuan, DING   +2 more
core  

Analysis of knowledge-based economy impact on economic development in the European Union countries [PDF]

, 2010
Directions of changes in the world economy occurring in recent years show the transition from industrial era economy to knowledge-based economy. Increasing investments in fixed assets is no longer a sufficient way of ensuring permanent economic growth ...
Dworak, Edyta
core   +1 more source

Determinants of corporate R&D expenditures: the role of taxes

, 2020
AT_PUBLICATION
Wasiluk, Dorota, Białek-Jaworska, Anna
openaire   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source

German Companies Do Less Research Abroad [PDF]

Germany has profited from the internationalization of research and development (R&D) in multinational companies. While the international R&D balance sheet was balanced until 2001, foreign companies now invest more in R&D in Germany than German companies ...
Heike Belitz
core  

Fetal Brain Tumor Harboring a Unique ROCK1::BRAF Fusion

Pediatric Blood &Cancer, EarlyView.
Marllon Cindra Sant'Ana, Mariana Maschietto, Daniela Paz Leal, Ricardo de Santos de Oliveira, Mayara Ferreira Euzébio, Antonio Carlos dos Santos, Luciano Neder, Carlos Alberto Scrideli, Elvis Terci Valera   +8 more
wiley   +1 more source

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Treatment‐associated hepatotoxicity (TAH) is a common complication of pediatric acute lymphoblastic leukemia (ALL) treatment, but genetic risk factors remain poorly understood. We evaluated the SOD2 rs4880 variant in 544 children with ALL at Texas Children's Hospital. After adjusting for demographic and clinical covariates, the rs4880 C allele
Emily J. Mason, John P. Woodhouse, Joanna S. Yi, M. Monica Gramatges, Olga A. Taylor, Veronica A. Morales, Shalini Dhamodharan, Marley Roberts, Karen R. Rabin, Philip J. Lupo, Michael E. Scheurer, Van Huynh, Steven D. Mittelman, Etan Orgel, Austin L. Brown   +14 more
wiley   +1 more source